NDC 82595-000

UPTRAVI

Selexipag

UPTRAVI is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eurofins Amatsigroup Sas. The primary component is Selexipag.

• Product ID: 82595-000_e1037fc6-9b27-5636-e053-2a95a90a6d29
• NDC: 82595-000
• Product Type: Human Prescription Drug
• Proprietary Name: UPTRAVI
• Generic Name: Selexipag
• Dosage Form: Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-07-29
• Marketing Category: NDA /
• Application Number: NDA214275
• Labeler Name: EUROFINS AMATSIGROUP SAS
• Substance Name: SELEXIPAG
• Active Ingredient Strength: 1800 ug/1
• Pharm Classes: Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 82595-000-01

1 VIAL in 1 CARTON (82595-000-01) > 1 POWDER, FOR SOLUTION in 1 VIAL

• Marketing Start Date: 2021-07-29
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "UPTRAVI" or generic name "Selexipag"

NDC	Brand Name	Generic Name
66215-602	UPTRAVI	Selexipag
66215-604	UPTRAVI	Selexipag
66215-606	UPTRAVI	Selexipag
66215-608	UPTRAVI	Selexipag
66215-610	UPTRAVI	Selexipag
66215-612	UPTRAVI	UPTRAVI
66215-614	UPTRAVI	UPTRAVI
66215-616	UPTRAVI	UPTRAVI